https://www.ophthotech.com/ 2024-09-25T03:01:54+00:00 https://www.ophthotech.com/happy-family-pharmacy/ 2024-11-20T14:55:59+00:00 https://www.ophthotech.com/about-ophthotech/translational-scientific-advisory-board/ 2024-09-26T00:21:48+00:00 https://www.ophthotech.com/about-amd/ 2024-09-24T00:00:06+00:00 https://www.ophthotech.com/contact/ 2024-09-24T07:14:27+00:00 https://www.ophthotech.com/about-ophthotech/management-team/ 2024-09-26T00:01:33+00:00 https://www.ophthotech.com/about-ophthotech/board-of-directors/ 2024-09-26T00:17:26+00:00 https://www.ophthotech.com/about-amd/patient-resources/ 2025-06-09T17:04:10+00:00 https://www.ophthotech.com/about-amd/wet-amd/ 2024-09-24T00:01:27+00:00 https://www.ophthotech.com/product-candidates/clinical-trials/ 2024-09-23T23:52:24+00:00 https://www.ophthotech.com/product-candidates/arc1905/ 2024-09-23T23:51:17+00:00 https://www.ophthotech.com/product-candidates/fovista/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/sitemap/ 2024-09-23T23:48:20+00:00 https://www.ophthotech.com/product-candidates/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/careers/ 2024-09-25T01:47:26+00:00 https://www.ophthotech.com/gene-therapy-research/ 2024-09-23T23:46:38+00:00 https://www.ophthotech.com/back-of-the-eye-diseases/ 2025-06-12T13:37:20+00:00 https://www.ophthotech.com/about-ophthotech/ 2024-09-23T23:40:37+00:00 https://www.ophthotech.com/ophthalmic-orphan-programs/ 2024-09-23T23:45:52+00:00 https://www.ophthotech.com/news/expanding-our-distribution-network/ 2025-10-27T14:05:12+00:00 https://www.ophthotech.com/news/ophthotech-to-present-at-30th-annual-j-p-morgan-healthcare-conference/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/positive-results-from-phase-2b-study-of-ophthotechs-novel-anti-pdgf-combination-agent-fovista-to-be-presented-at-aao-retina-subspecialty-day/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotechs-novel-anti-pdgf-combination-agent-fovista-demonstrated-superior-efficacy-over-lucentis-monotherapy-in-large-controlled-wet-amd-trial/ 2024-09-24T09:19:47+00:00 https://www.ophthotech.com/news/ophthotech-to-present-at-31st-annual-j-p-morgan-healthcare-conference/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-raises-175-million-to-finance-the-pivotal-phase-3-program-for-fovista-anti-pdgf-combination-therapy-in-wet-amd/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-files-registration-statement-for-proposed-initial-public-offering/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-prices-initial-public-offering/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-closes-initial-public-offering/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-to-report-third-quarter-2013-results-and-host-conference-call-on-wednesday-november-13-2013/ 2024-09-24T09:19:47+00:00 https://www.ophthotech.com/news/ophthotech-reports-third-quarter-2013-financial-results-and-provides-business-and-product-development-update/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-receives-41-7-million-in-second-tranche-in-royalty-financing-from-novo-as/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-to-present-at-the-32nd-annual-j-p-morgan-healthcare-conference/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-announces-pricing-of-public-offering-of-common-stock/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-to-announce-fourth-quarter-and-full-year-2013-financial-results-and-host-conference-call-on-thursday-february-27-2014/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-reports-fourth-quarter-and-full-year-2013-financial-and-operating-results/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-to-host-rd-day-on-march-7-2014/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-to-announce-first-quarter-2014-financial-results-and-host-conference-call-on-tuesday-may-13-2014/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-reports-first-quarter-2014-financial-results-and-provides-business-update/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-to-announce-second-quarter-2014-financial-results-and-host-conference-call-on-wednesday-august-6-2014/ 2024-09-24T10:03:19+00:00 https://www.ophthotech.com/news/ophthotech-corporation-enters-into-ex-us-licensing-and-commercialization-agreement-for-fovista-with-novartis/ 2024-09-24T09:19:47+00:00